首页> 外文期刊>International journal of clinical practice >Prospective cohort study of risk factors for extended‐spectrum ?‐lactamase‐producing Escherichia coli Escherichia coli urinary tract infections in elderly patients admitted to hospital
【24h】

Prospective cohort study of risk factors for extended‐spectrum ?‐lactamase‐producing Escherichia coli Escherichia coli urinary tract infections in elderly patients admitted to hospital

机译:延长光谱危险因素的预期队列研究 - 纳米酰亚胺酶的大肠杆菌大肠杆菌大肠杆菌尿道感染入院医院

获取原文
获取原文并翻译 | 示例
       

摘要

Summary Background Extended‐spectrum beta‐lactamase ( ESBL )‐producing Escherichia coli are currently common in community‐onset infections, limiting therapeutic options. In this work we aim to identify the prevalence of and risk factors for ESBL ‐producing E.?coli in elderly patients with urinary tract infections ( UTI ) admitted to hospital. Methods Prospective cohort study on elderly patients with E.?coli UTI admitted to a university hospital in Spain, from January 2013 to December 2015. Clinical features, microbiology and outcomes were recorded from the electronic medical records and reviewed by two researchers. Cases were segregated according to ESBL ‐producing E.?coli . Risk factors for ESBL ‐producing E.?coli were analysed by multivariate analysis. Results The prevalence of ESBL ‐producing E.?coli was 27.4% (85/310). Healthcare‐associated UTI was the only risk factor for ESBL ‐producing E.?coli ( OR 6.79; 95% CI 3.22‐14.31, P ??.001) by multivariate analysis. ESBL ‐producing E.?coli was 43.9% in the healthcare‐associated UTI group and 8.9% in the community‐acquired UTI group ( P ??.001). Inadequate empirical antibiotic therapy and length of stay in hospital were higher in the ESBL ‐producing E.?coli group than in the non‐ ESBL ‐producing E.?coli group (62.3% vs 5.3% and 6.60?±?3.69?days vs 5.61?±?3.16?days, respectively). Mortality was not significantly different between groups (13% in ESBL ‐producing E.?coli group vs 7.5% in non‐ ESBL ‐producing E.?coli group, P ?=?.140). Summary Healthcare‐associated UTI was a risk factor for ESBL ‐producing E.?coli in elderly patients with UTI admitted to hospital. Our results might help clinicians in choosing empirical antibiotics in an overall high rate setting of ESBL ‐producing E.?coli .
机译:发明内容背景扩展光谱β-内酰胺酶(ESBL) - 发布大肠杆菌目前常见于社区发作感染,限制治疗选择。在这项工作中,我们的目标是识别ESBL的患者和危险因素的患病率 - 在老年患有尿路感染(UTI)的老年患者中的E.OSCLI。方法对西班牙大学医院的老年患者前瞻性队列研究,2013年1月至2015年12月。从电子医疗记录中记录了临床特征,微生物学和结果,并由两位研究人员审查。根据ESBL进行分离的病例 - 发布E.?coli。通过多变量分析分析ESBL的危险因素 - 过量的E.?COLI。结果ESBL的患病率 - 同样为27.4%(85/310)。医疗保健相关的UTI是ESBL的唯一危险因素 - 通过多变量分析通过多变量分析来进行E.OSBOLI(或6.79; 95%CI 3.22-14.31,p≤001)。 ESBL-在医疗相关的UTI组中,在医疗保健相关UTI组中为43.9%,在社区获得的UTI组中为8.9%(P?& 001)。在ESBL中,在医院的经验抗生素治疗和住院时间较高,ESBLI组高于非ESBLI组(62.3%VS 5.3%和6.60?3.69?天与5.61?±3.16?分别为0.天。组之间的死亡率没有显着差异(ESBL中的13% - 在非ESBL中的E.?COLI组对7.5%的非E.?Coli组,P?= 140)。摘要医疗保健相关的UTI是ESBL的危险因素 - 在老年患者患有Enapated医院的老年患者中的危险因素。我们的结果可能有助于临床医生在ESBL的总体高速设定中选择经验抗生素 - 同样的E.?COLI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号